Associated Papers
STAT3 SH2 Domain Aspartic Acid 661 Mutations Activate Immune Gene Programs.
Lee HK et al.
Journal of Cellular and Molecular Medicine, 2026
Mouse Model of STAT3 Mutation Resulting in Job's Syndrome Diverges from Human Pathology.
Jankowski J et al.
International Journal of Molecular Sciences, 2025
SBNO2 is a critical mediator of STAT3-driven hematological malignancies.
Brandstoetter T et al.
Blood, 2023
Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
Kar SP et al.
Nature Genetics, 2022
STAT3 mutations in "gray-zone" cases of T-cell large granular lymphocytic leukemia associated with autoimmune rheumatic diseases.
Gorodetskiy V et al.
Frontiers in Medicine, 2022
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.
Frontzek F et al.
Nature Communications, 2021
Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.
Faletti L et al.
Biomedical Journal, 2021
Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
Gorodetskiy VR et al.
Rheumatology International, 2021
Simultaneous Presentation of Leukemic Non-Nodal Mantle Cell Lymphoma and Gamma-Delta T-Large Granular Lymphocytic Leukemia in a Patient with Rheumatoid Arthritis.
Gorodetskiy VR et al.
Cancer Management and Research, 2020
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED et al.
Cancers, 2019
Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma.
Chan JY et al.
Blood Cancer Journal, 2018
Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.
Menon MP et al.
The American Journal of Surgical Pathology, 2015
The Ying and Yang of STAT3 in Human Disease.
Vogel TP et al.
Journal of Clinical Immunology, 2015
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.
Creixell P et al.
Cell, 2015
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala HL et al.
Haematologica, 2015
Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
Rajala HL et al.
Annals of Medicine, 2014
Somatic STAT3 mutations in large granular lymphocytic leukemia.
Koskela HL et al.
The New England Journal of Medicine, 2012